Fidelity Investments
PRAX icon

Fidelity Investments’s Praxis Precision Medicines PRAX Stock Holding History

Fidelity Investments’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$696M Buy
2,160,943
+802,268
+59% +$248M 0.04% 399
2025
Q4 		$400M Buy
1,358,675
+1,315,464
+3,044% +$245M 0.02% 592
2025
Q3 		$2.29M Buy
43,211
+5,111
+13% +$248K ﹤0.01% 2494
2025
Q2 		$1.6M Buy
38,100
+2,381
+7% +$90.7K ﹤0.01% 2566
2025
Q1 		$1.35M Sell
35,719
-152,648
-81% -$9.53M ﹤0.01% 2580
2024
Q4 		$14.5M Sell
188,367
-85,528
-31% -$6.19M ﹤0.01% 1833
2024
Q3 		$15.8M Sell
273,895
-17,084
-6% -$923K ﹤0.01% 1790
2024
Q2 		$12M Sell
290,979
-151,642
-34% -$7.17M ﹤0.01% 1813
2024
Q1 		$27M Buy
442,621
+442,506
+384,788% +$19.9M ﹤0.01% 1553
2023
Q4 		$2.56K Sell
115
-13
-10% -$234 ﹤0.01% 4601
2023
Q3 		$3.29K Sell
128
-122
-49% -$2.31K ﹤0.01% 4426
2023
Q2 		$4.32K Buy
250
+208
+495% +$3.19K ﹤0.01% 4401
2023
Q1 		$509 Sell
42
-258
-86% -$10.9K ﹤0.01% 4791
2022
Q4 		$10.7K Sell
300
-29,702
-99% -$926K ﹤0.01% 3982
2022
Q3 		$1.02M Sell
30,002
-2,199
-7% -$110K ﹤0.01% 2602
2022
Q2 		$1.18M Sell
32,201
-274,657
-90% -$29.3M ﹤0.01% 2635
2022
Q1 		$47M Buy
306,858
+1,776
+0.6% +$365K ﹤0.01% 1413
2021
Q4 		$90.2M Sell
305,082
-5,373
-2% -$1.58M 0.01% 1148
2021
Q3 		$86.1M Sell
310,455
-3,074
-1% -$834K 0.01% 1171
2021
Q2 		$86M Buy
313,529
+27,581
+10% +$9.88M 0.01% 1186
2021
Q1 		$141M Buy
285,948
+45,547
+19% +$32.4M 0.01% 937
2020
Q4 		$198M Buy
+240,401
New +$140M 0.02% 749

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments's PRAX Position: Q1 2026 in Review

Fidelity Investments increased its Praxis Precision Medicines (PRAX) stake by 59% in Q1 2026, buying an estimated $248M and bringing the position to 2,160,943 shares worth $696M. The position accounts for 0.04% of the portfolio, ranked #399.

Fidelity Investments first reported a position in PRAX in Q4 2020 and has held it in 22 quarters since. 290 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Fidelity Investments held 2,160,943 shares of Praxis Precision Medicines worth $696M as of Q1 2026.
  • Fidelity Investments bought 802,268 Praxis Precision Medicines shares in Q1 2026, an estimated $248M.
  • Praxis Precision Medicines made up 0.04% of Fidelity Investments's portfolio in Q1 2026, its #399 holding.
  • Fidelity Investments first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 22 quarters since.
  • 290 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.